The number of new Covid-19 cases climbed to a six-month high in the United States, with more than 100,000 infections reported on Aug. 5 as the Delta variant ravages Florida and other states with lower vaccination rates.
North Carolina’s life sciences ecosystem continues to expand as Amgen announced plans to build a new $550 million biologics manufacturing center in Holly Springs in the Research Triangle Park area.
Walgreens Boots Alliance Inc. said on Aug. 4 the drugstore chain had administered more than 29 million Covid-19 vaccines at its stores so far, led by a surge in parts of the United States that had lagged in vaccinations.
U.S. President Joe Biden on Aug. 3 urged Republican leaders in Florida and Texas – home to roughly a third of all new U.S. Covid-19 cases – to follow public health guidelines on the pandemic or “get out of the way” as the country struggles to contain the rapid spread of the disease’s Delta variant.
New York City will become the first major U.S. city to require proof of Covid-19 vaccination for customers and staff at restaurants, gyms and other indoor businesses as the country enters a new phase of battling the highly contagious Delta variant.
With a new wave of Covid-19 infections fueled by the Delta variant striking countries worldwide, disease experts are scrambling to learn whether the latest version of coronavirus is making people – mainly the unvaccinated – sicker than before.
Combining AstraZeneca’s Covid-19 vaccine with a second dose from either Pfizer-BioNTech or Moderna’s jab provides “good protection”, Denmark’s State Serum Institute said on Aug. 2.
The Olympics host city Tokyo, as well as Thailand and Malaysia, announced record Covid-19 infections on July 31, mostly driven by the highly transmissible Delta variant of the disease.
An Illinois jury on July 30 refused to hold Johnson & Johnson liable for a woman’s death from ovarian cancer, which her family blamed on decades of using the company’s talc-based powders.
The U.S. Securities and Exchange Commission halted registrations of U.S. initial public offerings (IPOs) by Chinese companies.
